COVID-19, Acute Lymphoblastic Leukemia, and Down Syndrome: A Short Review and a Case Report

Case Reports in Oncology

Svetlana Senek¹  Tamara Makarova¹  Ahmed Arafat¹  Ayrat Ziatdinov¹  Natalya Samoilova¹  Dinara Sadykova¹ 

[1] Kazan State Medical University, Kazan, Russian Federation;

关键词: corona virus disease 2019;    acute lymphoblastic leukemia;    down syndrome;    infectious disease;   

DOI  :  10.1159/000516442

来源: DOAJ

【 摘 要 】

SARS-CoV-2 which causes COVID-19 has been a great challenge to treat and deal with; despite strict measures that had been implemented by governments and organizations, worrying rates of morbidity and mortality are still being reported. Although available data have expressed that moderate or even mild forms of the disease are expected amongst most pediatrics cases, minimal data are available on the prognosis and the disease’s complications on the immunocompromised, especially oncology patients. We report a case of relapsed precursor B-cell acute lymphoblastic leukemia of a child with Down syndrome and COVID-19 and outline the treatment regimen that we used.

【 授权许可】

Unknown